Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1953 - 1960 of 11616 results
Health Law Diagnosed – Digital Health During the PHE and Beyond: Leveraging Telehealth to Address Disparities in Access to Care
June 14, 2022| Podcast| Viewpoint
Show or Tell: A Road Map for Board Diversity Laws
June 13, 2022| News
A Road Map for Board Diversity Laws: Show or Tell
June 13, 2022| News
SEC Proposes Regulations to Address “Greenwashing” By Investment Funds
June 13, 2022| Blog| Viewpoint
DOJ Breaking with Big Tech Approach to SEPs
June 13, 2022| Blog| Viewpoint
Seizing Opportunity The Post-Pandemic Future of US Life Sciences M&A 2022
June 10, 2022| Article| Viewpoint
A Between The Biotech Waves Conversation With William Hicks
June 10, 2022| Podcast| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.